Literature DB >> 7675244

Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene.

V V Ionasescu1, R Ionasescu, C Searby, R Neahring.   

Abstract

We studied a 33-year-old woman with a negative family history. Both of her parents were examined clinically by nerve conduction velocities (NCVs) and EMG, with normal results. The clinical onset of her condition was at 24 months, with severe weakness and atrophy of her feet and hands, but the proximal muscles were relatively spared. She had bilateral pes cavus, distal weakness and hypesthesia for touch and proprioception, areflexia, claw hands, and severe thoracolumbar kyphoscoliosis. NCVs showed absent motor and sensory responses and EMG revealed diffuse fibrillation potentials. Molecular genetic studies indicated a de novo dominant missense point mutation of exon 3 of the peripheral myelin protein 22 gene at nucleotide 264 that caused the replacement of serine with leucine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675244     DOI: 10.1212/wnl.45.9.1766

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  A unique point mutation in the PMP22 gene is associated with Charcot-Marie-Tooth disease and deafness.

Authors:  M J Kovach; J P Lin; S Boyadjiev; K Campbell; L Mazzeo; K Herman; L A Rimer; W Frank; B Llewellyn; E W Jabs; D Gelber; V E Kimonis
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

2.  Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene.

Authors:  V V Ionasescu; C Searby; S A Greenberg
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.